August 10, 2016
  • Very Low LDL-C Levels Provide No Additional Protection From CV Events

    No additional protection against cardiovascular events was gained by achieving LDL-C of 70 mg/dL or less in a large group of patients with pre-existing ischemic heart disease, according to a large new study. Find out how the Israeli research could change the focus on statin treatment intensification.

  • Project Seeks to Include Medication Purpose
    on Prescriptions

    In the effort to make patients more knowledgeable about their healthcare, one key piece of information appears to be missing: the reason for a prescription. A recent perspective article urges that the purpose of the medication be included, and federal funding is being used to determine how to do that. Here are the details.

  • Biosimilars Appear to Be as Safe, Effective as Original Biologic Drugs
    Biologics can be complicated to manufacture, and concerns have been raised about whether biosimilars can be interchangeable with the original products. A new study indicates that they can. Find out how researchers came to that conclusion.
  • Combination Therapy Appears More Effective for ADHD in Children

    Two might be better than one when it comes to treating ADHD in children. A new study found combination therapy with two standard medications to be more effective for a range of symptoms. Here is more information.


Connect With U.S. Pharmacist
USP Google AppUSP Itunes App